• Home
  • About ISDB
    • What is ISDB?
    • Committee
    • Constitution
  • How to join
    • COI-forms
    • Criteria for membership
    • Application forms
  • Members
    • Bulletin index
    • Full members
    • Associated members
  • Publications
    • Newsletters
    • ISDB Publications
    • Press releases
    • Documents of interest
  • Campaigns
    • Working groups
    • Petitions
    • Future meetings
    • Past meetings
  • Intranet

ISDB – International Society of Drug Bulletins

International Society of Drug Bulletins

  • Home
  • About ISDB
    • What is ISDB?
    • Committee
    • Constitution
  • How to join
    • COI-forms
    • Criteria for membership
    • Application forms
  • Members
    • Bulletin index
    • Full members
    • Associated members
  • Publications
    • Newsletters
    • ISDB Publications
    • Press releases
    • Documents of interest
  • Campaigns
    • Working groups
    • Petitions
    • Future meetings
    • Past meetings
  • Intranet
  • Menu

A step backwards on pharmaceutical policy at the EU Commission: the move to directorate general (DG) Enterprise and Industry is unacceptable

September 16, 2014 Campaigns

Joint open letter to President Juncker by 28 organisations. Promoting profit over public health puts European citizens at risk. No, medicinal products are not just a commodity like any other.

Attachment: 20140916openletterpharmapolicy.pdf

Recent Publications

  • ISDB General Assembly Paris 2019
  • Newsletter ISDB 2019 vol. 32 nr. 1, March 2019
  • Cochrane’s sinking ship and conflicts of interest
  • Newsletter ISDB 2018 vol. 31 nr. 1, September 2018
  • Newsletter December 2017

Recent Campaigns

  • ISDB General Assembly Paris 2019
  • News from working groups: Clinical Study Reports?
  • News from working groups: Clinical Trials Group
  • A PRIME example of how EMA is pushing for accelerated market approvals, but at what cost for patients?
  • “Adaptive licensing” or “adaptive pathways”: Deregulation under the guise of earlier access

Contact

President
Dick Bijl
president@isdbweb.org

Webmaster
Uw Computerstudent
michael.wijnands@uwcomputerstudent.nl

Press releases

  • ISDB General Assembly Paris 2019
  • Cochrane’s sinking ship and conflicts of interest
  • No to EMA’s provision of confidential scientific advice to drug companies (November 2017)
  • Supplementary protection certificates (SPCs) delay access to affordable medicines (September 2017)
  • Proposed changes to EMA’s access to documents policy fall short on proactive disclosure (May 2017)

Newsletters

  • Newsletter ISDB 2019 vol. 32 nr. 1, March 2019
  • Newsletter ISDB 2018 vol. 31 nr. 1, September 2018
  • Newsletter December 2017
  • Newsletter November 2014
  • Newsletter March 2014

© 2019 ISDB – International Society of Drug Bulletins.